We support reforms which will allow  all Canadians to access the medicines they need when needed, equitably and consistently, as outlined in our core positions and principles, and in formal submissions.
National Strategy for High-Cost Drugs for Rare Diseases:
BMC’s Submission to the National Strategy for High-Cost Drugs for Rare Diseases Online Engagement (March 26, 2021)

Pharmacare Advisory Council:
BMC’s Position Points on Key Recommendations

Statement Regarding National Pharmacare Interim Report Announcement

National Pharmacare Implementation: Patient Perspectives and Considerations

Positions and Considerations Regarding National Pharmacare Funding Options

BMC Survey:
Patient Perspectives on National Pharmacare: Current Challenges, Goals and Implementation Issues

BMC Positions:
Submission to the House of Commons Standing Committee on Finance (August 2020)

Pharmacare Position Points: September 2019

Principles & Considerations Regarding Pharmacare

Submission: Standing Committee on Health

Joint Discussion Paper:
Better Pharmacare For Patients: Evaluating Policy Options (Français)